Last reviewed · How we verify
NCT03688815
Dipyridamole Induced Ischemia and Biomarkers
trial testing myocardial perfusion scintigraphy in Ischemic Heart Disease in 50 participants. Completed in 1 January 2017.
1 January 2010
Quick facts
| Lead sponsor | University of Pecs |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 January 2009 |
| Primary completion | 1 January 2010 |
| Estimated completion | 1 January 2017 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- myocardial perfusion scintigraphy
Conditions studied
- Ischemic Heart Disease — all drugs for Ischemic Heart Disease →
- Ischemic Attack — all drugs for Ischemic Attack →
Sponsor
University of Pecs
Who can join
Eligibility, any sex, with Ischemic Heart Disease or Ischemic Attack. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Analysis of certain biomarkers and transient myocardial perfusion deficit revealed by myocardial perfusion scintigraphy.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury.
Zhuang X, Shi S, Liu S, Jiao Y, et al · · 2025 · cited 4× · PMID 40365742 · DOI 10.1002/advs.202500566 -
Detection of silent cerebral microcirculatory abnormalities in patients with manifest ischemic coronary disease: a perfusion brain MRI study combined with dipyridamole stress.
Molnar T, Horvath A, Szabo Z, Vamos Z, et al · · 2021 · cited 2× · PMID 32945202 · DOI 10.1080/14017431.2020.1821911
Verify or expand the search:
- PubMed search for NCT03688815
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ischemic Heart Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT06712862 — A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR · recruiting
- NCT07009418 — Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien · NA · recruiting
- NCT06891456 — Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia · NA · recruiting
Other University of Pecs trials
Trials by the same sponsor.
- NCT07520877 — Effect of AED-optimized Telephone-assisted CPR Instructions on No-flow Time and Chest Compression Fraction · NA · recruiting
- NCT05060731 — Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding · Phase 4 · not yet recruiting
- NCT07101510 — V-CPR Under Special Circumstances · NA · completed
- NCT07068503 — Study of Running Injuries and Treatment Habits in Romanian Speakers · not yet recruiting
- NCT07044219 — The Effect of Chlorhexidine + Hyaluronic Acid on Postoperative Wound Healing After Lower Third Molar Removal · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03688815 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pecs
- Last refreshed: 28 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03688815.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing